Health-Related Quality-of-Life in a Randomized Phase III First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients from Asia with Advanced NSCLC (IPASS)
Year: 2011
Type: article
Source: Journal of Thoracic Oncology
Institutions: Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University, AstraZeneca (United Kingdom), Kindai University, Guangdong General Hospital, National Taiwan University, National Taiwan University Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Shanghai Chest Hospital, Taipei Veterans General Hospital, National Yang Ming University, Chang Gung Memorial Hospital, Taoyuan Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital, Hyogo Prefectural Cancer Center, Chinese University of Hong Kong
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: AstraZeneca
OpenAlex ID: W2041436152